News

San Diego, California--(Newsfile Corp. - February 18, 2020) - DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with ...
The Jersey City up-and-coming urban bachata group DNX 4 is ready for their Jersey Shore debut Saturday, Sept. 9, at the Latin Fest 2023 at Riley Park in Bradley Beach. Their rehearsals included a ...
DNX Ventures, an investment firm that focuses on early-stage B2B startups in Japan and the United States, announced today that it has closed a new $315 million fund. This is DNX’s third flagship ...
Pediatric patients with diffuse intrinsic pontine glioma (DIPG) have a poor prognosis, with a median survival of less than 1 year. Oncolytic viral therapy has been evaluated in patients with pediat ...
Application security platform NeuraLegion announced today it has raised a $4.7 million seed round led by DNX Ventures, an enterprise-focused investment firm.
Australian businesses Cevo and DNX Solutions were recognised as top Amazon Web Services (AWS) partners at the inaugural Regional and Global AWS Partner Awards. Hosted during AWS re:Invent 2022 in ...
The high-speed dome CCDA1435-DNX includes a 26x optical zoom day/night camera with exceptional low-light performance. A mechanically removable IR-cut filter allows the dome camera to provide good ...
Sydney-based cloud services provider DNX Solutions is seeing slower leads and longer sales cycles amid "tough" conditions, a trend that has continued since the last financial quarter.
DNX-2401 (Delta-24-RGD; tasadenoturev) is a tumor-selective, replication-competent oncolytic adenovirus. Preclinical studies demonstrated antiglioma efficacy, but the effects and mechanisms of action ...